April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Characterization of Commercially Available Human RPE Cell Culture from LONZA®
Author Affiliations & Notes
  • Bikash R. Pattnaik
    Pediatrics, Ophthal & Visual Sci, Eye Research Institute,
    Univ of Wisconsin, Madison, Wisconsin
  • Fan Yang
    LONZA Walkersville Inc., Walkersville, Maryland
  • Sara Tokarz
    Pediatrics,
    Univ of Wisconsin, Madison, Wisconsin
  • Simran Brar
    Pediatrics,
    Univ of Wisconsin, Madison, Wisconsin
  • Matti P. Asuma
    Pediatrics,
    Univ of Wisconsin, Madison, Wisconsin
  • Marjorie Smithhisler
    LONZA Walkersville Inc., Walkersville, Maryland
  • De-Ann M. Pillers
    Pediatrics, Eye Research Institute,
    Univ of Wisconsin, Madison, Wisconsin
  • Footnotes
    Commercial Relationships  Bikash R. Pattnaik, LONZA Walkersville Inc. (R); Fan Yang, LONZA Walkersville Inc. (E); Sara Tokarz, None; Simran Brar, None; Matti P. Asuma, None; Marjorie Smithhisler, LONZA Walkersville Inc. (E); De-Ann M. Pillers, None
  • Footnotes
    Support  Rebecca Meyer Brown Professorship, UW School of Medicine and Public Health, UW Institute for Clinical and Translational Research and by NIH grant 1UL1RR025011
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 871. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bikash R. Pattnaik, Fan Yang, Sara Tokarz, Simran Brar, Matti P. Asuma, Marjorie Smithhisler, De-Ann M. Pillers; Characterization of Commercially Available Human RPE Cell Culture from LONZA®. Invest. Ophthalmol. Vis. Sci. 2011;52(14):871.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Malfunction of retinal pigment epithelium (RPE) cells distorts the function of neurosensory retina and hence affects our vision. A viable approach to study disease mechanism and RPE physiology is to make available suitable RPE cells in culture which can also be used in gene and transplantation therapy. We have characterized the cryopreserved Clonetics® Human Retinal Pigment Epithelial (hRPE) cells (# 00194987) from LONZA Walkersville Inc.

Methods: : Human RPE cells were isolated and cultured using optimized RtEGMTM growth medium BulletKit® (# 00195409). RPE cells were characterized by immunohistochemistry of pancytokeratin, Na+K+ATPase, ZO-1, CD31 and fibroblast marker for cell identity and purity. After the cells formed a tight monolayer with hexagonal morphology, they were enzymatically dispersed and used for electrophysiology analysis using standard whole cell patch-clamp method. RPE specific transcripts were detected by RT-PCR.

Results: : Human RPE cells showed pigmented hexagonal monolayer after 4-6 days in culture. These cells expressed Kir7.1, bestrophin, pancytokeratin, Na+K+ATPase and ZO-1 but not endothelial and fibroblast markers. Unlike other RPE cells in culture, most of these cells showed inwardly rectifying K+-current. This current was significantly (4.5 ± 2.3 fold 12 of 12 cells) enhanced by application of Rb+ solution as this is a unique property of the RPE specific Kir7.1 channel. These cells tested positive for RPE specific transcripts.

Conclusions: : This study demonstrated that commercially available Clonetics®human RPE cells from LONZA in RtEGMTM medium retain both molecular and electrophysiological phenotypes making them suitable for the study of disease mechanisms involving RPE. They can thus be used for the investigations of age-related macular degeneration, retinitis pigmentosa, determining gene expression profiles of RPE cells and potentially for subsequent transplantation studies.

Keywords: retinal pigment epithelium • electrophysiology: non-clinical • microscopy: light/fluorescence/immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×